Interview with Jonathan Browning, Chairman of British Cycling

The transcript discusses the initial reactions to operational gaps in medical services, focusing on the need for clear questions and actions. Concerns about missing medical records and expectations for record-keeping are addressed. The issue of triamcinolone and the lack of an audit trail is explored, with emphasis on working with anti-doping agencies to ensure proper processes and controls. Finally, concerns about a potential drug culture in British Cycling are discussed, with a focus on maintaining a clean organization.

What concerns were raised about the drug triamcinolone?

How does the organization plan to demonstrate that it is a clean organization?